Home » Stocks » MACK

Merrimack Pharmaceuticals, Inc. (MACK)

Stock Price: $6.52 USD -0.05 (-0.76%)
Updated Mar 8, 2021 3:59 PM EST - Market closed
After-hours: $6.58 +0.06 (0.92%) Mar 8, 4:00 PM
Market Cap 90.32M
Revenue (ttm) n/a
Net Income (ttm) 1.34M
Shares Out 13.38M
EPS (ttm) 0.10
PE Ratio 65.20
Forward PE n/a
Dividend $1.50
Dividend Yield 22.96%
Trading Day March 8
Last Price $6.52
Previous Close $6.57
Change ($) -0.05
Change (%) -0.76%
Day's Open 6.73
Day's Range 6.44 - 6.80
Day's Volume 53,696
52-Week Range 1.49 - 9.45

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 4 months ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals Q3 2020 Earnings Release

Business Wire - 7 months ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Reports Second Quarter 2020 Financial Results

Seeking Alpha - 10 months ago

Merrimack Pharmaceuticals: SCLC Presents A Lower Hurdle For Approval Than Initially Assumed

Seeking Alpha - 1 year ago

Merrimack Pharmaceuticals - A Better Way To Invest In Biotechnology

Seeking Alpha - 1 year ago

Merrimack Pharmaceuticals is a special-situations investment.

24/7 Wall Street - 1 year ago

Merrimack Pharmaceuticals Inc. has announced that it will be discontinuing one of its cancer drugs, as well as conducting layoffs.

About MACK

Merrimack Pharmaceuticals operates as a biopharmaceutical company. The company was incorporated in 1993 and is based in Cambridge, Massachusetts.

Industry
Biotechnology
IPO Date
Mar 29, 2012
CEO
Gary L. Crocker M.B.A., MBA
Stock Exchange
NASDAQ
Ticker Symbol
MACK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for MACK is 4.00, which is a decrease of -38.65% from the latest price.

Price Target
$4.00
(-38.65% downside)